This website is being migrated. In case you don't find the information you are looking for, the old website can be found here. Thank you for reporting any anomalies to communication@ill.eu.

News

250109_Monoclonal Antobody.jpg
Jan. 10, 2025 Never diffuse alone: understanding antibody teamwork to design tomorrow's therapeutics
Monoclonal antibodies (mAbs) are used to treat a large variety of diseases. In order to allow patients to inject these therapeutic molecules autonomously, it is crucial to understand the origin of and to control their viscosity. An international team of researchers used an interdisciplinary approach to understand how molecular interactions and motions influence the viscosity of different mAbs. The study has now been published in the journal Molecular Pharmaceutics.
220215_JACS_vignette.jpg
Feb. 15, 2022 Neutron scattering techniques reveal the roles of SARS-CoV-2 fusion peptides during infection
Research has demonstrated the likely critical membrane fusion mechanism involved when the SARS-CoV-2 coronavirus infects human cells.SARS-CoV-2, the virus responsible for the COVID-19 pandemic, is from a family of single-stranded positive sense RNA viruses named β-coronaviruses. SARS-CoV-2 and oth…